Search Results
Oct 14, 2025, 01:40 ET 2025 ACR Abstract Released! Exciting Data from Telitacicept's Phase III Clinical Study in Sjögren's Syndrome in China
week 24, -4.4 (160mg), -3.0 (80mg), and -0.6 (placebo); at week 48, -4.6 (160mg), -3.2 (80mg), and -0.4 (placebo), demonstrating durable, dose-dependent improvement in systemic disease activity. Mean change in ESSPRI: At week 24, -1.88 (160mg), -1.31 (80mg), and -0.36 (placebo);
More news about: RemeGen Co., Ltd
Oct 13, 2025, 19:30 ET LEQEMBI® IQLIK™(lecanemab-irmb) Subcutaneous Autoinjector Named to TIME's "Best Inventions of 2025"
(lecanemab-irmb) is available: Intravenous infusion: 100 mg/mL Subcutaneous injection: 200 mg/mL Please see full
More news about: Eisai Inc.
Oct 13, 2025, 17:31 ET Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight
therapeutic choices and improving patient outcomes. Additionally, the ongoing research and development of novel therapies, such as Immunotek's MM09, MG01 + T517, and MG56, are expected to sustain long-term market expansion.
More news about: DelveInsight Business Research, LLP
Oct 13, 2025, 15:03 ET Algae Products Market to Reach USD 9.7Billion by 2032, Growing At An 7% CAGR - Credence Research
October 2024 – DSM-Firmenich launched life's DHA B54-0100, a high-potency algal oil containing 545 mg DHA and 80 mg EPA per gram. This innovation enables smaller supplement capsules and addresses global omega-3 deficiency. The launch marks a major advancement
More news about: Credence Research Inc.
Oct 13, 2025, 14:34 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Pomerantz LLP
Oct 13, 2025, 10:57 ET U.S. Food and Drug Administration (FDA) Approves Updated Indication Statement for RINVOQ® (upadacitinib) for the Treatment of Inflammatory Bowel Disease
tablet. Take RINVOQ exactly as your HCP tells you to use it. RINVOQ is available in 15 mg, 30 mg, and 45 mg extended-release tablets. RINVOQ LQ is taken twice a day with or without food. RINVOQ LQ is available in a 1 mg/mL oral solution. RINVOQ LQ is not the same as RINVOQ tablets. Do not switch between
More news about: AbbVie
Oct 13, 2025, 09:00 ET GC Biopharma Highlights IVIG Innovation and Investigator-Initiated Research as Science to Solutions Partner at the Fall 2025 CIIC Conference
About ALYGLO®ALYGLO® (immune globulin intravenous, human-stwk) is a glycine-stabilized 10% immunoglobulin G (100 mg/mL) for intravenous infusion, manufactured from pooled human plasma from US donors. The manufacturing process includes multiple steps to reduce the risk
More news about: GC Biopharma USA Inc.
Oct 13, 2025, 08:00 ET Atossa Advances Global Patent Strategy for Z-Endoxifen with New Protection in Israel and Ongoing Renewals
Z-endoxifen, with optional impurity limits (<2%), defined release characteristics in gastric and intestinal media, dose strengths (e.g., 1–4 mg and 8 mg), and pharmacokinetic performance targets (e.g., plasma exposures and steady-state levels). The claims also cover manufacturing methods that enrich
More news about: Atossa Therapeutics Inc
Oct 13, 2025, 08:00 ET U Power Reports Unaudited Financial Results for the First Half of 2025
Company signed an agreement with a local ESP, to deploy 5,000 swappable EVs and a corresponding number of UOTTA™ stations, while converting 300 existing MG EP taxis into swappable taxis. Portugal:In 2025, the Company developed a strategic partnership
More news about: U Power Limited
Oct 13, 2025, 07:15 ET AbbVie to Present New Data at ESMO 2025 Reinforcing Leadership in Advancing Targeted Therapies for Solid Tumors
NCT05029882), treatment with 2.4 mg/kg dose of Temab-A plus Bev (n=30) achieved an objective response rate (ORR) of 26.7% compared to an ORR of 0% with trifluridine/tipiracil with Bev (the
More news about: AbbVie
Oct 13, 2025, 06:45 ET Lilly to present new clinical data for Verzenio (abemaciclib) and multiple novel pipeline programs at the 2025 European Society for Medical Oncology (ESMO) Annual Meeting
of 200 mg twice daily or 150 mg twice daily, reduce the Verzenio dose to 100 mg twice daily with concomitant use of strong CYP3A inhibitors other than ketoconazole. In patients who have had a dose reduction to 100 mg twice daily due to adverse reactions, further reduce the Verzenio dose to 50 mg twice
More news about: Eli Lilly and Company
Oct 12, 2025, 18:27 ET Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib in Patients with NSCLC with EGFR mutations and Active Brain Metastases at the ESMO Congress 2025
cutoff, 32 patients were enrolled in the CNS involvement cohort of the ongoing parallel cohort Phase 2b REZILIENT2 trial and received zipalertinib 100 mg orally twice daily. Patients received a median of 2 prior lines of therapy, and of all patients enrolled, 21 patients had ex20ins mutations and 13 patients
More news about: Taiho Oncology
Oct 12, 2025, 18:22 ET IsoEnergy to Acquire Toro Energy, Strengthening a Top-Tier Uranium Portfolio in a Rising Market
omni-directional, and directional variograms using the one metre U3O8 composite values located within the LG and MG mineralized domains. The MG domain variogram was calculated using composites located within MG and HG wireframes to allow for more pairs in the analysis. The variograms were used to support search
More news about: IsoEnergy Ltd.
Oct 10, 2025, 20:05 ET SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Faruqi & Faruqi, LLP
Oct 10, 2025, 07:30 ET Johnson & Johnson to highlight breadth of its major depressive disorder portfolio at 2025 ECNP Congress
trials with CAPLYTA vs. placebo were somnolence/sedation, dizziness, nausea, and dry mouth. CAPLYTA is available in 10.5 mg, 21 mg, and 42 mg capsules.
More news about: Johnson & Johnson
Oct 09, 2025, 16:15 ET Endo Announces Nine New and Modified Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
announced today that nine presentations related to Peyronie's disease, or PD, and XIAFLEX® (collagenase clostridium histolyticum, injection 0.9 mg) will be shared during the Sexual Medicine Society of North America (SMSNA) annual meeting, taking place October 9-12, 2025.
More news about: Endo USA, Inc.
Oct 09, 2025, 11:41 ET Nootropics Depot's Erinamax Sets Industry Benchmark with Market-Leading Erinacine A Standardization
Erinamax Lion's Mane mycelium capsules. Independent laboratory analysis indicates that Erinamax is standardized to 2.5 mg of erinacine A per capsule, providing a consistent serving of this important bioactive compound.
More news about: Nootropics Depot
Oct 09, 2025, 11:14 ET Jumex® and AriZona Expand Partnership with the Launch of Jumex Energy™, a Fruit-Forward Energy Drink
Lightly carbonated for fizzy refreshment, the new Jumex Energy™ line includes Mango and Strawberry blends. Each energy fruit nectar is enhanced with 150 mg of caffeine, Vitamins C, B5, B6, B12, and a performance blend of taurine, guarana, and ginseng to help provide energy and focus support .
More news about: Grupo Jumex
Oct 09, 2025, 10:00 ET Starter Bakery Opens Solano Avenue Café in Albany
https://drive.google.com/drive/folders/1PGwG4UskL8VoyXGEYJFgnhK2P-WY8mg6?usp=sharing Website:
More news about: Starter Bakery Solano
Oct 09, 2025, 08:46 ET Melts™ Launches Line of Dissolvable Supplement Strips to the Public at GetMelts.com
Melts Passion™ – Designed to support performance and desire. Melts™ NAD+ – A revitalizing strip delivering 100mg of NAD+ without needles. Melts Glow™ – Featuring ingredients like BPC-157, TB500, and GHK-Cu to support recovery and repair.
More news about: Melts™ LLC
Oct 08, 2025, 19:30 ET Astellas to Present New Data on IZERVAY™ (avacincaptad pegol intravitreal solution) in Geographic Atrophy at AAO 2025 Annual Meeting
trials. These trials evaluated the safety and efficacy of monthly 2 mg intravitreal administration of IZERVAY in patients with GA secondary to AMD. For the first 12 months in both trials, patients were randomized to receive either IZERVAY 2 mg or sham monthly. There were 286 participants enrolled in GATHER1
More news about: Astellas Pharma Inc.
Oct 08, 2025, 16:30 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain Officers - JSPR
2025, Jasper issued a press release reporting updated data from the BEACON Study. The press release stated that "[r]esults from the 240mg Q8W and the 240mg followed by 180mg Q8W dose cohorts appear to be confounded by an issue with one drug product lot used in those cohorts, with 10 of the 13 patients dosed
More news about: Pomerantz LLP
Oct 08, 2025, 15:59 ET Physician and New York Times Bestselling Author Dr. Michael Greger Releases New Book
Dennis then expand this portfolio with creative ways to incorporate all known foods and safe supplements that have been shown to lower LDL by at least 10 mg/dL (0.26 mmol/L). For the latest information on evidence-based weight loss, nutrition, and health, visit
More news about: NutritionFacts
Oct 08, 2025, 09:07 ET Eat Almonds to Support a Healthy Gut
provides 6g of protein, 4g of fiber, 13g of unsaturated fat, only 1g of saturated fat, and 15 essential nutrients, including 77mg magnesium (18.3% DV), 210mg potassium (4%DV), and 7.27mg vitamin E (50% DV). They make a great snack, are perfect for topping cereal or yogurt, and are a delicious addition to stir
More news about: Almond Board of California
Oct 08, 2025, 08:46 ET Bragg® Expands Retail Footprint with Pineapple Turmeric Apple Cider Vinegar Blend Rolling Out in Whole Foods Market Stores
pineapple and the slightly spicy kick of turmeric, a widely celebrated spice. Each bottle includes Bragg's legendary naturally fermented "Mother" and 750mg of acetic acid per serving for time-tested wellness benefits with a bold, invigorating twist. "At Bragg, innovation starts with
More news about: Bragg Live Food Products